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Abstract
The G2 fusion subunit of the Junin virus envelope glycoprotein GP-C contains two hydrophobic heptad-repeat regions that are postulated to 
form a six-helix bundle structure required for the membrane fusion activity of Class I viral fusion proteins. We have investigated the role of these 
heptad-repeat regions and, specifically, the importance of the putative interhelical a and d position sidechains by using alanine-scanning 
mutagenesis. All the mutant glycoproteins were expressed and transported to the cell surface. Proteolytic maturation at the subtilisin kexin 
isozyme-1/site-1-protease (SKI-1/S1P) cleavage site was observed in all but two of the mutants. Among the adequately cleaved mutant 
glycoproteins, four positions in the N-terminal region (1333, L336, L347 and L350) and two positions in the C-terminal region (R392 and W395) 
were shown to be important determinants of cell-cell fusion. Taken together, our results indicate that a-helical coiled-coil structures are likely 
critical in promoting arenavirus membrane fusion. These findings support the inclusion of the arenavirus GP-C among the Class I viral fusion 
proteins and suggest pharmacologic and immunologic strategies for targeting arenavirus infection and hemorrhagic fever.
© 2005 Elsevier Inc. All rights reserved.
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Introduction
Arenaviruses are endemic in rodent populations worldwide 
(Salazar-Bravo et al., 2002) and are transmitted to humans by 
exposure to infected animals. Infection by Old World 
arenaviruses such as Lassa virus, or New World species such 
as the South American group including Junin, Machupo and 
Guanarito viruses, are responsible for recurring and emerging 
outbreaks of viral hemorrhagic fevers with high mortality 
(McCormick and Fisher-Hoch, 2002; Peters, 2002). Prophy­
lactic and therapeutic options to combat arenavirus infection 
are limited, and the development of effective immunogens and 
antiviral agents to interfere with arenavirus entry may have 
broad public health benefits.
The arenaviruses are enveloped bisegmented RNA viruses 
whose genome consists of two single-stranded RNA molecules 
(Buchmeier et al., 2001; Clegg et al., 2000). During biogenesis, 
arenaviral particles assemble and bud at the plasma membrane. 
The mature envelope glycoprotein complex of the arenavirus 
consists of three noncovalently associated subunits derived 
from the GP-C precursor by proteolytic cleavage events: a 
stable myristoylated 58 amino-acid signal peptide (SSP), the 
receptor-binding G1 subunit and the transmembrane G2 fusion 
protein (Buchmeier, 2002; Eichler et al., 2003; York et al., 
2004). The initial cleavage to yield SSP is likely mediated by 
the cellular signal peptidase, and the mature G1 and G2 
subunits are subsequently generated by the cellular SKI-1/S1P 
protease. Both cleavage events, as well as the presence of the 
myristoylated SSP subunit, are required for envelope glyco- 
protein-mediated membrane fusion (York et al., 2004). Entry of 
virion particles into host cells is initiated by G1 binding to cell 
surface receptors followed by endocytosis of the virion into 
smooth vesicles (Borrow and Oldstone, 1994). Although a- 
dystroglycan serves as a binding receptor for the Old World 
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arenaviruses (Cao et al., 1998), the receptor utilized by the 
major New World group of arenaviruses is unknown (Spiro- 
poulou et al., 2002). Membrane fusion is pH-dependent and is 
activated upon acidification of the maturing endosome (Borrow 
and Oldstone, 1994; Castilla et al., 1994; Di Simone and 
Buchmeier, 1995; Di Simone et al., 1994).
The molecular basis for envelope glycoprotein-mediated 
membrane fusion in the arenaviruses is largely unknown, 
however, sequence analysis of the G2 ectodomain of Lassa 
virus and lymphocytic choriomeningitis virus (LCMV) has 
revealed two heptad-repeat regions that can be represented to 
form amphipathic helices (Gallaher et al., 2001). This sequence 
motif is found among the large group of viral envelope 
glycoproteins that promote membrane fusion through the 
formation of a fusion-active core structure comprising a stable 
bundle of six a-helices. These Class I fusion proteins include 
those of the retroviruses, orthomyxoviruses, paramyxoviruses, 
filoviruses and coronaviruses. In these proteins, the six-helix 
bundle structure involves a central coiled coil, formed by N- 
terminal heptad-repeat regions of the trimeric fusion subunit 
ectodomain, surrounded by three anti-parallel helices of the C- 
terminal heptad repeats which bind to the conserved hydro- 
phobic grooves on the coiled-coil surface. Formation of this 
thermodynamically favored six-helix bundle brings the viral 
and cell membranes into apposition and is thought to provide 
the driving energy to initiate membrane fusion (Earp et al., 
2005; Eckert and Kim, 2001; Hughson, 1997; Weissenhom et 
al., 1999 and references therein). In keeping with the proposal 
that the arenavirus G2 ectodomain might also form a fusion­
active six-helix bundle, Gallaher and colleagues have shown 
that a synthetic peptide derived from the N-terminal heptad­
repeat region of LCMV is able to assume a-helical content 
(Gallaher et al., 2001).
In this report, we have utilized alanine-scanning mutagen­
esis of the heptad-repeat regions of the New World Junin 
arenavirus envelope glycoprotein to obtain genetic evidence in 
support of this model for membrane fusion in the arenaviruses. 
We show that mutations at predicted interhelical positions 
affect the ability of the envelope glycoprotein complex to 
mediate pH-dependent cell-cell fusion. These findings suggest 
that membrane fusion by the arenavirus envelope glycoprotein 
complex is promoted via a refolding into a highly stable six- 
helix bundle structure characteristic of Class 1 viral fusion 
glycoproteins.
Results and discussion
Sequence analysis of the G2 ectodomain of the Junin 
arenavirus
The amino acid sequences of the heptad repeats of New 
World and Old World arenaviruses were aligned to demonstrate 
the high degree of conservation within the family (Fig. 1A). 
One key consideration in assigning a register to the proposed 
helical coiled coil of the heptad repeats (i.e., positions a 
through g) was to maximize the degree of hydrophobicity at 
the interhelical a and d positions. Upon inspection of the 
aligned sequences, a unique register of a and d positions was 
apparent (Figs. 1A and B). The a and d positions of the 
proposed N-terminal helix consist of hydrophobic residues 
common to the central interface of a trimeric coiled coil (e.g., 
leucine, isoleucine, methionine and valine). Positions assumed 
to lie on the exterior face of the coiled coil (b, c and f 
positions) contain polar or charged residues. This pattern is 
repeated through the C-terminal heptad-repeat region and 
appears to end at the C-terminal-most d and a positions 
(K409 and D413, respectively). Hydrophilic residues at two a 
positions in the New World viruses (R392 and S399) are 
replaced by less polar amino acids in the Old World viruses 
(serine and alanine, respectively). The hydrophilic sidechains, 
if buried, may impart specificity to the process of coiled-coil 
folding at the expense of thermal stability (Ji et al., 2000; Lumb 
and Kim, 1995).
Expression o f Junin virus envelope glycoproteins bearing 
alanine mutations at a and d positions
To investigate the proposed a-helical structures and their 
role in promoting membrane fusion in the arenaviruses, we 
subjected the heptad-repeat regions of the Junin virus envelope 
glycoprotein to scanning mutagenesis. Each a and d position 
amino acid was individually changed to alanine, a small 
residue that is a good helix inducer yet contributes little to the 
hydrophobic forces that predominantly stabilize coiled-coil 
structures. Alanine substitutions at these positions are likely to 
alter the stability of the proposed six-helix bundle, but not to 
disrupt its overall folding. We anticipated that alanine muta­
tions at interhelical positions within the coiled-coil bundle may 
selectively affect the ability of the envelope glycoprotein to 
mediate membrane fusion.
For these studies, we utilized the GP-C gene of the 
pathogenic Junin virus isolate MC2 (York et al., 2004). The 
wild-type and mutant plasmids were introduced in Vero 76 
cells, and the envelope glycoproteins were expressed using the 
T7 promoter of the plasmid vector and T7 RNA polymerase 
provided by infection with the recombinant vaccinia virus 
vTF7-3 (Fuerst et al., 1986). Cultures were metabolically 
labeled and subsequently solubilized. The envelope glycopro­
teins were immunoprecipitated using the mouse MAb BF11 
(Sanchez et al., 1989) directed to the G1 subunit (York et al., 
2004).
We have previously shown that the Junin virus envelope 
glycoprotein complex isolated by immunoprecipitation retains 
the three noncovalently associated subunits: the mature G1 
and G2 glycoproteins as well as the stable signal peptide, SSP 
(York et al., 2004 and see Fig. 2). Cleavage by signal 
peptidase and the SKI-1/S1P protease are incomplete upon 
recombinant expression such that two precursor glycoproteins 
(full-length GP-C and the G1-G2 precursor lacking SSP) are 
observed. The glycoproteins isolated by immunoprecipitation 
of the wild-type envelope glycoprotein, and an SKI-1/S1P 
cleavage-site mutant (cd-JGPC; York et al., 2004), are 
illustrated in Fig. 2A (far left). The two precursor glycopro­
teins migrate with molecular weights of 65 kDa and 60 kDa,
J. York et al. / Virology 343 (2005) 267-274 269
SSP G1 G2
1 ,YY , Y Y SKI-1 /SIPl l!iiii Y. Y.YY . ...
Hi 1 1 N C TM| cyto |
1 5« 251 ,____ I 481
Junin
325 353
QVNLMGQTINALISDNLLMKNKIRELMSV
Tacaribe RVNVLSHTINALISDNLLMKNKIRELMSV
Machupo EIN FLSQTVNALIS DNLLMKNKIRELMSV 
Guanarito AVNMLTHSINSLISDNLLMRNKLKEILKV
Lassa-J
Mopei
LCMV-A
SIQLINKAVNALINDQLIMKNHLRDIMGI 
SINLINKAVNALINDQLVMRNHLRDLMGI 
ALHLFKTTVNSLISDQLLMRNHLRDLMGV
382 413
NNSYLNISDFRNDWILESDFLISEMLSKEYSD
NNSYLNSSEFRNEWILESDFLISEMLSKEYSE
NGSYLNISEFRNDWILESDHLISEMLSKEYÁE
NGSYLNESDFRNEWlLESDHLIAEMLSKEYQD
NGSYLNETHFSDDIEQQADNMITEMLQKEYME
NGSYLMETQFSTEIEQEANNMFTDMLRKEYEK
NGSYLNETHFS'DQIEQEADNMITEMLRKDYIK
B.
Gin Ser
Thr Phe
Leu Asp Asn Glu
Ala Lys Met Asp Glu
Leu Vai Leu Phe Ser lie
Glu Met Ser Trp
.bW-. Leu Leu
Lys
Gin (ft N-helix A Asn (X C-helix ft
Ser Asp
Asn a Vai Leu \ .. Tyr
Ser G”— lie Ser f.b < e y Arg
Asn Asn T*r Leu Ser
Asn Gly lie Asn Asn Met
Leu lie Asp Ser Asp
Arg Lys Leu lie
Met lie
Glu
Fig. 1. Schematic representation of the Junin vims GP-C glycoprotein and N- and C-terminal heptad-repeat regions. (A) Amino acids of the Junin vims envelope 
glycoprotein are numbered from the initiating methionine, and cysteine residues (|) and potential glycosylation sites (Y) are marked. The SSP and SKI-1/S1P 
cleavage sites and the resulting SSP, G1 and G2 subunits are indicated. Within G2, the C-terminal transmembrane (TM) and cytoplasmic (cyto) domains are shown, 
as are the N- and C-terminal heptad-repeat regions (light gray shading). A comparison of heptad-repeat sequences among arenavims species is detailed below. 
Sequences include the New World isolates Junin (D10072), Tacaribe (M20304), Machupo (AY129248) and Guanarito (AAN05423) and Old World isolates Lassa- 
Josiah (Ml 5076), Mopeia (M33879), LC MV-Armstrong (M20869). The 3,4 periodicity of« and d heptad-repeat positions is indicated by shading. (B) Helical wheel 
projections of proposed heptad-repeat periodicity. Amino acids shown above are listed in numeric order at a -g positions. A schematic of a six-helix bundle is at the 
lower right, and the details of the canonical interhelical packing arrangement are illustrated.
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Fig. 2. Expression of wild-type and mutant envelope glycoproteins. (A) Metabolically labeled glycoproteins were immunoprecipitated using the G1-specific MAb 
BF11 and separated on NuPAGE 4 -12% Bis - Tris gels. The wild-type (wt) and SKI-1/S1P cleavage-defective (cd) glycoproteins are shown for comparison with the 
N- and C-terminal heptad-repeat mutants. V326A indicates the glycoprotein in which V326 has been changed to alanine. The two bands labeled GP-C (i.e., the full- 
length GP-C and the G1-G2 precursor lacking SSP) as well as the heterodisperse smear of G1 are better resolved following deglycosylation using PNGase F (B).
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respectively. The mature G2 glycoprotein appears as a band of 
»35 kDa, whereas the heterogeneous smear of the G1 
glycoprotein is difficult to discern. These bands are better 
resolved following deglycosylation using peptide:N-glycosi- 
dase F (PNGase F) (Fig. 2B, far left). The G1 and G2 subu­
nits are absent in the cleavage-defective cd-JGPC envelope 
glycoprotein.
Among the seventeen N- and C-terminal heptad-repeat 
mutants, all the GP-C glycoproteins were expressed, and all 
were cleaved by signal peptidase to generate the 5 kDa SSP 
(Fig. 2A). The relative efficiencies of SKI-1/S1P protease 
cleavage, however, varied among the mutants (Figs. 2A and B). 
In some mutants (e.g., Y385A and L402A), SKI-1/S1P 
cleavage was undetectable, similar to that in the cleavage- 
site-defective envelope glycoprotein. In other mutants, the 
amounts of cleavage ranged from markedly reduced to levels 
greater than those in the wild-type. To quantitate the relative 
extents of SKI-1/S1P processing, we determined the amount of 
radioactivity present in the deglycosylated GP-C precursors 
and in the mature G1 and G2 polypeptides using a Fuji 3000-G 
phosphorimager and Image Gauge software (Fuji). Our 
analysis of two independent experiments is shown in Fig. 3.
Several classes of mutants could be defined by this 
analysis. Proteolytic maturation was essentially absent in the 
Y385A and L402A mutants and significantly reduced in 
L350A and W395A (30 and 45% of wild-type levels, 
respectively). Other mutants were cleaved much as the wild­
type glycoprotein (L336A, N340A, I388A, R392A, S399A, 
M406A and K409A; from 65 to 100% of wild-type levels), 
whereas several mutations in the N-terminal heptad-repeat
Fig. 3. Quantitation of SKI-1/S1P cleavage and the formation of the mature G1 
and G2 subunits. Phosphorimages of the deglycosylated polypeptides 
represented in Fig. IB were analyzed using Image Gauge software (Fuji) and 
the Profile and Background tools to quantitate the radioactivity (PSL units). 
The efficiency of SKI-1/S1P cleavage was defined as the ratio of PSL units in 
the sum of the G1 + G2 peaks relative to the total number in both GP-C and 
G1 + G2 peaks. Results were analyzed for two complete experiments, and the 
relative conclusions are consistent with those of additional partial studies. 
Because the absolute efficiency of cleavage varied between experiments, each 
experiment was normalized to the average extent of cleavage in the entire 19- 
member panel. This average ratio (16% and 24% in the two complete 
experiments shown here) was used to determine the relative degree of cleavage 
in each mutant, and these numbers were averaged to generate the values 
plotted. By this analysis, the wild-type envelope glycoprotein was cleaved 
1.17-fold better than the arbitrary average of the panel; 100% and 50% of the 
wild-type level are shown as dashed lines. Error bars represent ± one standard 
deviation.
region appeared to enhance proteolytic cleavage up to 2-fold 
(V326A, M329A, I333A, M343A and I347A). Shedding of 
the mature G1 subunit into the culture supernatant correlated 
with the extent of SKI-1/S1P cleavage (not shown). Although 
proteolytic processing varied among the mutants, all but two 
showed significant cleavage of the G1-G2 precursor.
Transport of the mutant envelope glycoprotein complexes 
to the cell surface was determined by flow cytometry using 
the Gl-specific MAb BE08 (Sanchez et al., 1989). Cells from 
cultures transiently transfected to express the wild-type and 
cd-JGPC glycoproteins displayed two populations: cells 
expressing GP-C (>30 fluorescence channel) and those that 
escaped transfection (<30 fc) (Fig. 4). Proteolytic maturation 
of the arenavirus envelope glycoprotein complex is clearly not 
required for transport to the cell surface. In fact, staining of 
the cleavage-defective mutant cd-JGPC was generally higher 
and more discrete than that of the wild-type envelope 
glycoprotein, likely due to shedding of the G1 subunit from 
the wild-type but not the cleavage-defective complex (York et 
al., 2004). Among the heptad-repeat mutants (Fig. 4), all 
patterns of staining were within this range and qualitatively 
similar. We conclude that transport of the mutant glycopro­
teins to the cell surface was not markedly affected.
The precise pattern of cell-surface staining is expected to 
reflect the degree of transport and the relative extent of G1 
shedding. Our efforts to further characterize the surface GP-C 
complex biochemically were limited by the refractory nature of 
the GP-C complex to covalent modification by standard 
biotinylation reagents (unpublished). Overall, however, suc­
cessful entry into the Golgi and transit to the cell surface 
suggests that the mutations do not globally perturb the 
structural integrity of the mutant GP-C complexes.
Mutations at interhelical positions affect pH-dependent 
cell-cell fusion
The effects of the alanine mutations on the ability of the 
envelope glycoprotein to mediate pH-dependent cell-cell 
fusion were determined in Vero 76 cells using the recombinant 
vaccinia virus-based LacZ fusion reporter assay (Nussbaum et 
al., 1994) as described (York et al., 2004). In this assay, |'>- 
galactosidase expression initiated by fusion of the effector and 
target cells was determined using a chemiluminescent substrate 
(GalactoLite Plus, Tropix). The extent of pH-dependent cell­
cell fusion mediated by the wild-type and mutant envelope 
glycoproteins is shown in Fig. 5.
Five alanine substitutions at a and d positions reduced 
fusogenicity to less than 10% of the wild-type GP-C or 
comparably to the SKI-1/S1P cleavage-site mutation in cd- 
JGPC: I333A in the N-terminal heptad repeat and Y385A, 
R392A, W395A and L402A in the C-terminal heptad repeat 
(Fig. 5). Although the lack of proteolytic cleavage in Y385A 
and L402A is likely sufficient to account for the defect in 
fusion by these mutants, the other glycoproteins (13 3 3A, 
R392A and W385A) showed significant levels of cleavage. 
Three additional mutations in the N-terminal region (L336A, 
I347A and L350A) reduced cell-cell fusion to less than 50%
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Fig. 4. Flow cytometric analysis of cell-surface envelope glycoprotein. Vero cells expressing the envelope glycoproteins were stained using the Gl-specific 
neutralizing MAb BEOS (Sanchez et al., 1989) and subsequently stained using propidium iodide (1 pg/ml) to exclude dead cells in the population. Cells were fixed 
using 2% formaldehyde and analyzed using a FACSCalibur flow cytometer (BD Biosciences). Background staining of mock-transfected cells is shown in the first 
panel; the non-expressing cell population within the GP-C transfected cultures (other panels) tend to pick up additional staining, possibly due to membrane exchange 
within the culture. The expressing cell populations were defined using a gate of >30 that included <0.1% of the mock-transfected population (arrow).
of the wild type. In all cases, cell-cell fusion required exposure 
of the culture to acidic (pH 5.0) medium.
In some mutants, clear defects in membrane fusion arose 
despite wild-type levels of SKI-1/S1P cleavage (viz., I333A 
and I347A). In others, it was difficult to determine whether the 
deficiencies in cell-cell fusion were directly attributable to the 
envelope glycoprotein fusion machinery or to defects in SKI-1/ 
SIP proteolytic processing. In several examples, mutants 
displaying reductions in cleavage efficiency were able to 
mediate cell-cell fusion much as the wild-type glycoprotein 
(viz., I388A and S399A), whereas other comparably cleavage­
deficient mutants were defective in membrane fusion (viz., 
L336A, L350A and R392A). These observations suggested 
that the variable deficiencies in SKI-1/S1P cleavage were not 
sufficient to account for the majority of the defects in cell-cell 
fusion under our assay conditions.
In order to more fully examine this point, we reconstructed 
the variable extents of proteolytic cleavage using mixtures of 
the wild-type and SKI-1/S1P cleavage-site mutant plasmids. In 
these studies, we determined the relative efficiencies of SKI-1/ 
SIP cleavage by PAGE and the extent of pH-dependent 
membrane fusion in the recombinant vaccinia virus-based 
LacZ fusion reporter assay (Fig. 6). Although the total amount 
of envelope glycoprotein remained constant as the wild-type 
plasmid was diluted 1:3 and 1:9 with cd-JGPC (90% and 85% 
of the undiluted wild-type level, respectively), the relative 
amounts of mature G1 and G2 decreased progressively, from 
20% to 5% and 2%, respectively. Despite a 90% decrease in 
overall SKI-1/S1P cleavage, however, cell-cell fusion was 
unaffected. Within these limits, our measurements of cell-cell 
fusion appear not to be sensitive to the relative amounts of 
proteolytically matured G1 and G2 glycoprotein, and we infer 
that mutants in which SKI-1/S1P cleavage is retained to at least 
10% of the wild type level can be informative in defining 
specific defects in membrane fusion.
Tertiary effects of the heptad-repeat mutations that may 
indirectly affect both proteolytic cleavage and fusogenicity, 
such as those that influence overall protein folding, trafficking
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Fig. 5. Fusogenic potential of wild-type and mutant envelope glycoproteins. The 
ability of the envelope glycoproteins to mediate pH-dependent cell-cell fusion 
was detected using the recombinant vaccinia virus-based ^-galactosidase 
reporter assay (Nussbaum et al., 1994) as described in Materials and methods, 
^-galactosidase activity induced upon cell-cell fusion was quantitated using the 
chemiluminescent substrate GalactoLite Plus (Tropix). Background levels of 
chemiluminescence obtained from cultures treated at neutral pH were subtracted 
from the relative light unit (RLU) measurement, and all RLU values were then 
normalized to that of the wild-type GP-C control. Error bars represent ± one 
standard deviation among 6 replicate fusion cultures. All conclusions were 
replicated using X-gal staining of parallel co-cultures (York et al., 2004).
or oligomer composition, would limit our ability to generalize 
from oui' simple reconstitution model. In the case of the 
cleavage-site defective glycoprotein, these considerations are 
likely moot as GP-C biogenesis appears to be otherwise blind 
to the SKI-1/S1P site mutation. Among the heptad-repeat 
mutants, we also observe no evidence for global defects in 
folding, assembly or transport and thereby extend the 
interpretation of the model experiment to these glycoproteins. 
Thus, we conclude that the following a and d heptad-repeat 
positions contribute directly to promoting pH-dependent 
membrane fusion by the Junin virus envelope glycoprotein: 
1333, L336, 1347 and L350 in the N-terminal region and R392 
and W395 in the C-terminal region.
Arenavirus GP-C is likely a member of the Class I fusion 
proteins
Taken together, our studies identify a series of amino acid 
residues within the N- and C-terminal heptad-repeat regions of 
the G2 ectodomain that impair the ability of the Junin virus 
envelope glycoprotein to mediate pH-dependent cell-cell 
fusion. The residues chosen for mutagenic analysis were 
modeled to lie at interhelical a and d positions, in keeping 
with the predominant role of these positions for coiled-coil 
formation. Alanine substitutions at these positions are often 
benign (Luo and Weiss, 1998), and the rich appearance of 
fusion-deficient phenotypes among our mutants is consistent 
with this model and with the important role of the a-helical 
coiled-coil bundle in promoting membrane fusion in the 
arenaviruses.
Several of the alanine mutations also affected SKI-1/S1P 
cleavage of the G1-G2 precursor glycoprotein, presumably 
through conformational effects that otherwise do not perturb 
envelope glycoprotein trafficking to the cell surface. These 
effects on proteolytic cleavage may signal a distinct role of the 
heptad-repeat regions in the folding of the native envelope 
glycoprotein during biogenesis. Importantly, our studies 
suggest that these effects on proteolytic cleavage per se are 
unlikely to account for the specific deficiencies in membrane 
fusion activity.
These genetic studies provide direct support to the proposal, 
originally based on amino acid sequence analysis (Gallaher et 
al., 2001), that membrane fusion in the arenaviruses is 
promoted by the formation of an a-helical coiled-coil structure 
similar to that described in the Class I viral fusion proteins. 
Biophysical evidence emerging from the laboratory of M. Lu 
(Weill Medical College of Cornell University) confirms that 
peptides derived from the N- and C-terminal heptad repeats of 
the Junin virus G2 associate to form a six-membered trimeric 
structure with a high degree of helical content and thermal 
stability (unpublished). The precise limits of the N- and C- 
terminal a-helices and the details of the interhelical interactions 
within the arenavirus six-helix bundle await atomic-level 
structure determination.
The inclusion of the arenavirus envelope glycoprotein 
within this class of viral fusion proteins suggests several 
specific strategies towards the development of vaccines and 
therapeutic agents against arenavirus infection. Peptides 
derived from the C-terminal helical region of the HIV fusion 
protein that are believed to irreversibly interfere with 
formation of the six-helix bundle are in clinical use in the 
treatment of HIV disease (Kilby et al., 2002), and small 
molecule inhibitors may be feasible (Eckert et al., 1999). 
Similarly, broadly neutralizing antibodies that target the 
membrane-proximal region of the HIV gp41 ectodomain 
adjacent to the C-terminal heptad repeat (Muster et al., 1993; 
Stiegler et al., 2001; Zwick et al., 2001) may likewise 
interfere in this process (Follis et al., 2002). Further structural 
and immunochemical studies of the arenavirus envelope 
glycoprotein complex may point to conserved mechanisms 
and broadly applicable strategies towards the prevention and 
treatment of arenaviral hemorrhagic fevers.
Fig. 6. Reconstruction to determine the effect of variable SKI-1/SIP cleavage 
efficiency on envelope glycoprotein fusogenic potential. Vero 76 cells were 
transfected with 4 pg DNA containing either the wild-type GP-C plasmid (wt), 
a 1:3 mixture of the wt and cd-JGPC plasmids, respectively, or a 1:9 mixture of 
the same plasmids. Parallel cultures were metabolically labeled and immuno­
precipitated, and PNGase F-treated polypeptides were analyzed as described in 
Figs. 2 and 3 (A) or subjected to the recombinant vaccinia virus-based fusion 
assay as described in Fig. 5 (B).
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Materials and methods
Molecular reagents, recombinant vaccinia viruses and 
monoclonal antibodies
The GP-C gene (Ghiringhelli et al., 1991) of the pathogenic 
MC2 isolate of the Argentine hemorrhagic fever (Junin) virus 
was expressed using the bacteriophage T7 polymerase pro­
moter in a pcDNA3.1-based (Invitrogen) expression plasmid 
(York et al., 2004). The GP-C gene was modified to express an 
innocuous S-peptide (Spep) affinity tag (Kim and Raines, 
1993 ) at the cytoplasmic C-terminus to facilitate manipulations 
(York et al., 2004). The (3-galactosidase fusion reporter assay 
(Nussbaum et al., 1994) was used to assess the ability of the 
envelope glycoprotein to mediate receptor-dependent cell-cell 
fusion. The recombinant vaccinia virus vCB21R-lacZ expres­
sing (3-galactosidase under the control of the T7 promoter 
(Nussbaum et al., 1994) was obtained from C. Broder, P. 
Kennedy and E. Berger (NIH) through the AIDS Research and 
Reference Reagent Program. Mouse monoclonal antibodies 
(MAbs) directed to the G1 subunit of GP-C (Sanchez et al., 
1989) were kindly provided by Drs. Tom Ksiasek and Tony 
Sanchez (Special Pathogens Branch, CDC, Atlanta).
Expression of GP-C
The envelope glycoprotein was transiently expressed in 
Vero 76 cells using the pcDNA3.1-based T7 promoter and the 
recombinant vaccinia virus encoding T7 polymerase vTF7-3 
(Fuerst et al., 1986). Vero cells were infected with the 
recombinant vaccinia virus at a multiplicity of two in 
Dulbecco’s Minimal Essential Medium (DMEM) containing 
2% fetal bovine serum (FBS). Cytosine arabinoside (araC) 
was included at 10 pM to limit vaccinia virus expression 
(Hruby et al., 1980). After 30 min, the cells were washed and 
transfected with the GP-C expression plasmid using Lipofec- 
tamine 2000 reagent (Invitrogen). Metabolic labeling using 32 
jiCi/ml of [35S]-ProMix (Amersham Pharmacia Biotech) was 
initiated 6 h post-transfection in methionine- and cysteine-free 
DMEM containing 10% dialyzed FBS and 10 pM araC and 
was continued for 12-16 h. Cultures were then washed in 
physiological buffered saline (PBS) and lysed using cold 
Tris-saline buffer (50 mM Tris-HCl and 150 mM NaCl at 
pH 7.5) containing 1% Triton X-100 nonionic detergent and 
protease inhibitors (1 pg/ml each of aprotinin, leupeptin and 
pepstatin). A soluble fraction was prepared by centrifugation 
at 15,000xg for 30 min at 4 °C. The expressed glycoproteins 
were isolated either by immunoprecipitation using the Gl- 
directed MAb BF11 (Sanchez et al., 1989) and Protein A- 
Sepharose (Sigma) or by using the C-terminal (G2) Spep 
affinity tag and S-protein agarose (Novagen). In some 
experiments, the isolated glycoproteins were deglycosylated 
using peptide:N-glycosidase F (PNGase F, New England 
Biolabs). Glycoproteins and polypeptides were resolved using 
NuPAGE 4-12% Bis-Tris gels (Invitrogen) and the recom­
mended sample buffer containing lithium dodecyl sulfate and 
reducing agent. Molecular weight markers included [14CJ- 
methylated Rainbow proteins (Amersham Pharmacia Bio­
tech). Radiolabeled proteins were imaged using a Fuji FLA- 
30000 imager and analyzed using ImageGauge software 
(Fuji).
Flow cytometry
Vero 76 cells transiently expressing the wild-type and 
mutant glycoproteins were labeled using the Gl-specific 
MAb BE08 (Sanchez et al., 1989) and a secondary fluorescein 
isothiocyanate (FITC)-conjugated goat anti-mouse antibody 
(Jackson ImmunoResearch). Cells were subsequently stained 
using propidium iodide (1 pg/ml) and then fixed in 2% 
formaldehyde. Populations were analyzed using a FACSCali- 
bur flow cytometer and CellQuest software (BD Biosciences).
Envelope glycoprotein-mediated cell-cell fusion
The (3-galactosidase fusion reporter assay (Nussbaum et al., 
1994) was used to assess the ability of the envelope 
glycoproteins to mediate receptor-dependent cell-cell fusion. 
In these studies, Vero cells infected with vTF7-3 and expressing 
the envelope glycoprotein were co-cultmed with Vero cells 
infected with vCB21R-lacZ, a recombinant vaccinia virus 
expressing (3-galactosidase under the control of the T7 
promoter. These latter (target) cells were obtained by incubat­
ing Vero 76 cells with a multiplicity of two vCB21R-lacZ 
plaque-forming units per cell and allowing the infection to 
proceed overnight in the presence of 100 pg/ml of the vaccinia 
virus assembly inhibitor, rifampicin. After mixing of the 
envelope glycoprotein-expressing and target cells in medium 
containing both araC and rifampicin (Hruby et al., 1980; York 
et al., 2004), the co-cultures were continued for 5 h prior to 
being subjected to a 30 min pulse of neutral or acidic (pH 5.0) 
medium as previously described (York et al., 2004). |'>- 
galactosidase expression is induced upon fusion of the effector 
and target cells and was detected, after 5 h of continued 
cultivation at neutral pH, in cell lysates (Tropix) using the 
chemiluminescent substrate GalactoLite Plus (Tropix). Cell­
cell fusion was quantified using a Tropix TR717 microplate 
luminometer.
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